3-hydroxy-3-methyl-3-glutaryl coenzyme A reductase inhibitors (statins), reduce the expression of chemokines, such as CCL2 and CXCL8, and matrix metalloprotease (MMP) 9, all of which are increased in COPD [19]. Here, CXCL8 is linked to chronic obstructive pulmonary disease.